Average cost of multi drug-resistant tuberculosis treatment in Myanmar
Myanmar: Average cost of multi drug-resistant tuberculosis treatment was 468 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
468 constant 2022 US$
Change on year
down 48.7%
World rank
80th
of 92 countries
All-time high
1,352 constant 2022 US$
in 2019
All-time low
468 constant 2022 US$
in 2024
Years of data
8
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in Myanmar, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2024, average cost of multi drug-resistant tuberculosis treatment in Myanmar stood at 468 constant 2022 US$. That is the lowest value across all 8 years on record.
Compared with earlier readings it is down 48.7% on the previous year and down 57.5% over ten years.
Myanmar ranks 80th of 92 countries on this measure, in the bottom quarter.
Average cost of multi drug-resistant tuberculosis treatment in Myanmar, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 1,100 constant 2022 US$ | — |
| 2018 | 1,100 constant 2022 US$ | +0.0% |
| 2019 | 1,352 constant 2022 US$ | +22.9% |
| 2020 | 1,352 constant 2022 US$ | +0.0% |
| 2021 | 994 constant 2022 US$ | -26.5% |
| 2022 | 994 constant 2022 US$ | +0.0% |
| 2023 | 912 constant 2022 US$ | -8.2% |
| 2024 | 468 constant 2022 US$ | -48.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,184 constant 2022 US$ | 1,100 constant 2022 US$ | 1,352 constant 2022 US$ | 3 |
| 2020s | 944 constant 2022 US$ | 468 constant 2022 US$ | 1,352 constant 2022 US$ | 5 |
Countries ranked near Myanmar
- 77 Madagascar 532 constant 2022 US$ compare
- 78 Cape Verde 500 constant 2022 US$ compare
- 78 Ghana 500 constant 2022 US$ compare
- 81 Bangladesh 466 constant 2022 US$ compare
- 82 Pakistan 460 constant 2022 US$ compare
- 83 Viet Nam 458 constant 2022 US$ compare
More health data for Myanmar
- Un projection of annual infant deaths, annual growth rate -2.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1576 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,398 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,973 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 7 (2025)
- Total tetanus - number of reported cases, per capita 0 units per person (2025)
- Diphtheria - number of reported cases, gaps filled 107 (2025)
- Diphtheria - number of reported cases, per capita 0 units per person (2025)
- Measles - number of reported cases, gaps filled 9 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Myanmar?
- Average cost of multi drug-resistant tuberculosis treatment in Myanmar was 468 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Myanmar?
- The highest recorded value was 1,352 constant 2022 US$ in 2019.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Myanmar?
- The lowest recorded value was 468 constant 2022 US$ in 2024.
- How does Myanmar rank for average cost of multi drug-resistant tuberculosis treatment?
- Myanmar ranks 80th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Myanmar?
- Over the last ten years it is down 57.5%. The long-run trend across the full record is falling.
- Where does this Myanmar data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.